Company intelligence / Profile preview

Addor Capital

Nanjing, Jiangsu, Chinacn.linkedin.com ↗

Ownership: Private
Employees: ~89
Development stage: Other

Overview

Not applicable; as an investor, does not have clinical results. Has invested in over 1,000 companies and supported more than 200 IPOs or listings

Industry: Investors

Partnerships

Invested in numerous startups and growth companies across healthcare and other sectors; specific partnerships with pharma/biotech firms are through portfolio investments rather than direct operational partnerships.

Beyond the preview

Go deeper on Addor Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Addor Capital.

Explore the full profile